PODXL and cancer: It has been hypothesized that the normal function of Podocalyxin is to act as an “apicalizing” factor and an anti-adhesin that can disrupt cell-cell contacts between epithelial cells, and that overexpression can lead to altered morphologies associated with cancer progression [8], [11], [12].